Children’s Hospital at Montefiore Einstein
Children's Hospital at Montefiore Einstein (CHAM) is a cornerstone in pediatric healthcare, annually serving a diverse community of over 200,000 children and spearheading advancements in medical research and education. Since 2001, with $476 million in research funding, including more than $200 million from the National Institutes of Health (NIH), CHAM has maintained its position as a leader in pediatric research. As a premier academic institution, CHAM is committed to cultivating future pediatric leaders with a curriculum focused on quality improvement, ethics, health equity and social justice, ensuring the highest standard of care for all children.
DATA & STATISTICS
2024 by the numbers
160K+
children in the community received pediatric care
5K+
pediatric emergency department visits
240+
peer-reviewed papers published
$381M
secured in research funding, including more than $200M from NIH
INNOVATIONS & ACHIEVEMENTS
Shaping the future of pediatric treatment and care
CELEBRATING CHAM'S 2024 AWARDS AND ACHIEVEMENTS
A year of recognition and advancements in pediatric healthcare excellence
Denise J. Nunez, MD, Visits the Vatican
On May 18, 2024, Dr. Denise Nunez met with Pope Francis as part of a private tour at the Vatican with providers from SOMOS Community Care.
Team News
Updates and additions to our world-renowned faculty
Advancing pediatric healthcare through research
Annually, CHAM provides care for over 8,000 hospitalized infants, children and adolescents with complex conditions, including 1,200 in its pediatric critical care unit and around 1,000 critically ill newborns in neonatal intensive care units. Additionally, nearly 200,000 children are treated through pediatric ambulatory care, and 44,000 receive care in school-based health programs.
CHAM is recognized for groundbreaking research leading to new therapies and better outcomes. In 2024, CHAM received over $48 million in grants and contracts, with $15 million from the NIH, ranking it among the top 35 institutions for pediatric disease funding nationally.
Clinical Trials
Advancing care through clinical trials
Children's Hospital at Montefiore Einstein participates in both national and clinical trials, a selection of which are highlighted below.
An Open-label, Single-arm, Multicohort, Phase 2 Study to Assess the Efficacy and Safety of Tabelecleucel in Subjects with Epstein-Barr Virus-associated Diseases (EBVision)
David Loeb
An Adaptive, Randomized, Placebo-controlled, Double-blind, Multi-center Study of Oral Etavopivat, a Pyruvate Kinase Activator in Patients With Sickle Cell Disease (HIBISCUS)
Deepa Manwani
Testing the Feasibility of a Teletherapy Plus Parent Coaching Intervention for Children With Autism
Elizabeth Ridgway
A Prospective, Long-Term Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
Leslie Delfiner
Cast your vote
Polls on Doximity close soon. We hope you’ll consider nominating Children’s Hospital at Montefiore Einstein (CHAM) for the U.S. News & World Report Best Hospitals survey.
Visit us
Children’s Hospital at Montefiore Einstein
3415 Bainbridge Ave
Bronx, NY 10467